Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
30.66B | 29.82B | 30.36B | 28.72B | 22.14B | 19.71B | Gross Profit |
6.61B | 10.51B | 10.70B | 11.36B | 8.57B | 7.15B | EBIT |
3.00B | 3.52B | 3.23B | 4.08B | 3.31B | 2.02B | EBITDA |
5.26B | 5.29B | 5.15B | 6.41B | 6.39B | 2.59B | Net Income Common Stockholders |
1.05B | 978.00M | 2.30B | 2.68B | 3.32B | -204.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
2.38B | 2.35B | 2.38B | 2.77B | 3.25B | 4.00B | Total Assets |
56.39B | 53.77B | 56.39B | 53.42B | 49.82B | 43.52B | Total Debt |
18.24B | 0.00 | 18.24B | 16.38B | 16.87B | 18.20B | Net Debt |
15.86B | -2.35B | 15.86B | 13.61B | 13.63B | 14.20B | Total Liabilities |
33.60B | 31.37B | 33.60B | 31.50B | 30.12B | 29.12B | Stockholders Equity |
20.06B | 19.58B | 20.06B | 19.55B | 17.36B | 13.39B |
Cash Flow | Free Cash Flow | ||||
2.91B | 3.04B | 1.75B | 2.48B | 2.58B | 1.50B | Operating Cash Flow |
5.34B | 5.50B | 4.43B | 4.50B | 4.18B | 3.14B | Investing Cash Flow |
-2.16B | -2.44B | -3.58B | -2.68B | -2.29B | -1.44B | Financing Cash Flow |
-2.68B | -2.57B | -816.00M | -2.74B | -2.87B | 1.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | €19.62B | 39.39 | 5.17% | 2.69% | -1.78% | -55.55% | |
74 Outperform | €11.81B | 21.02 | 2.89% | 7.89% | 52.48% | ||
71 Outperform | €44.83B | 45.41 | 4.93% | 2.33% | -1.78% | -57.52% | |
65 Neutral | $8.88B | 15.01 | 4.76% | 203.76% | 3.54% | -2.49% |